Who Wins the Battle Against Obesity? A Network Meta‐Analysis Comparing Tirzepatide and Semaglutide
ABSTRACT Introduction Pharmacological therapies are recommended for individuals with obesity. Semaglutide, a glucagon‐like peptide‐1 receptor agonist (GLP‐1), and tirzepatide, a dual glucose‐dependent insulinotropic polypeptide and GLP‐1 receptor agonist (GIP/GLP‐1), are among the leading pharmacolo...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley
2026-02-01
|
| Colección: | Journal of Diabetes |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1111/1753-0407.70192 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|